GB2308065B - Treatment of multiple sclerosis (MS) and other demyelinating conditions - Google Patents

Treatment of multiple sclerosis (MS) and other demyelinating conditions

Info

Publication number
GB2308065B
GB2308065B GB9707065A GB9707065A GB2308065B GB 2308065 B GB2308065 B GB 2308065B GB 9707065 A GB9707065 A GB 9707065A GB 9707065 A GB9707065 A GB 9707065A GB 2308065 B GB2308065 B GB 2308065B
Authority
GB
United Kingdom
Prior art keywords
treatment
multiple sclerosis
demyelinating conditions
demyelinating
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
GB9707065A
Other versions
GB9707065D0 (en
GB2308065A (en
Inventor
Cari Loder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420116A external-priority patent/GB9420116D0/en
Priority claimed from GBGB9508482.8A external-priority patent/GB9508482D0/en
Application filed by Individual filed Critical Individual
Priority to GB9707065A priority Critical patent/GB2308065B/en
Priority claimed from PCT/GB1995/002361 external-priority patent/WO1996011009A1/en
Publication of GB9707065D0 publication Critical patent/GB9707065D0/en
Publication of GB2308065A publication Critical patent/GB2308065A/en
Application granted granted Critical
Publication of GB2308065B publication Critical patent/GB2308065B/en
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
GB9707065A 1994-10-05 1995-10-05 Treatment of multiple sclerosis (MS) and other demyelinating conditions Revoked GB2308065B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9707065A GB2308065B (en) 1994-10-05 1995-10-05 Treatment of multiple sclerosis (MS) and other demyelinating conditions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9420116A GB9420116D0 (en) 1994-10-05 1994-10-05 A therapeutic drug treatment for compensating for the effects of nerve damage caused by multiple sclerosis and other demyelinating conditions
GBGB9508482.8A GB9508482D0 (en) 1995-04-26 1995-04-26 A therapeutic drug treatment for compensating for the effects of nerve damage caused by multiple sclerosis and other demyelinating conditions, and the product
PCT/GB1995/002361 WO1996011009A1 (en) 1994-10-05 1995-10-05 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound
GB9707065A GB2308065B (en) 1994-10-05 1995-10-05 Treatment of multiple sclerosis (MS) and other demyelinating conditions

Publications (3)

Publication Number Publication Date
GB9707065D0 GB9707065D0 (en) 1997-05-28
GB2308065A GB2308065A (en) 1997-06-18
GB2308065B true GB2308065B (en) 1999-01-13

Family

ID=27267414

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9707065A Revoked GB2308065B (en) 1994-10-05 1995-10-05 Treatment of multiple sclerosis (MS) and other demyelinating conditions

Country Status (1)

Country Link
GB (1) GB2308065B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2628558A1 (en) * 1975-07-03 1977-01-20 Leo Ab PROCESS FOR THE PREPARATION OF LOFEPRAMINE HYDROCHLORIDE
GB2082910A (en) * 1980-08-28 1982-03-17 Berk Pharmaceuticals Ltd Anti-depressant compositions
US4409243A (en) * 1981-11-09 1983-10-11 Julian Lieb Treatment of auto-immune and inflammatory diseases
DE3519687A1 (en) * 1985-06-01 1986-12-04 Veit Arend Pharmaceutical containing amino acids
US4650789A (en) * 1985-10-15 1987-03-17 Commonwealth Medical Corporation Of America Method and composition for increasing production of serotonin
DE4204102A1 (en) * 1992-02-12 1993-08-19 Kragler Peter Pharmaceutical compsn. to treat folate metabolic disorders - contains methionine, vitamin B cpd., thymine, 5-methylcytosine and penicillin g

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2628558A1 (en) * 1975-07-03 1977-01-20 Leo Ab PROCESS FOR THE PREPARATION OF LOFEPRAMINE HYDROCHLORIDE
GB2082910A (en) * 1980-08-28 1982-03-17 Berk Pharmaceuticals Ltd Anti-depressant compositions
US4409243A (en) * 1981-11-09 1983-10-11 Julian Lieb Treatment of auto-immune and inflammatory diseases
DE3519687A1 (en) * 1985-06-01 1986-12-04 Veit Arend Pharmaceutical containing amino acids
US4650789A (en) * 1985-10-15 1987-03-17 Commonwealth Medical Corporation Of America Method and composition for increasing production of serotonin
DE4204102A1 (en) * 1992-02-12 1993-08-19 Kragler Peter Pharmaceutical compsn. to treat folate metabolic disorders - contains methionine, vitamin B cpd., thymine, 5-methylcytosine and penicillin g

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Biochem.Pharmacol. 42(4) pages 921-929 (1991) *
Handbook of affective disorders Edited by E.S.Paykel pages 327-343 (1992) *
J.Immunopharmacol. 4(3),pages 153-162 (1983) *
J.Neuroimmunol. 40(2-3), pages 225-230 (1992) *
J.Neurol.Sci. 35(1), pages 157-166 (1978) *
Neurosci.Lett. 141(1), pages 35-38 (1992) *

Also Published As

Publication number Publication date
GB9707065D0 (en) 1997-05-28
GB2308065A (en) 1997-06-18

Similar Documents

Publication Publication Date Title
GB9310241D0 (en) Cosmetic treatment of substrates
ZA945426B (en) Treatment of tachyarrhytmias of supraventricular origin
IL115015A0 (en) Methods of inhibiting demyelinating and desmyelinating diseases
IL115766A0 (en) Composition and treatment for multiple sclerosis
GB9324773D0 (en) Treatment of cellulose
EP0557388A4 (en) Diagnosis and treatment of multiple sclerosis
IL113661A0 (en) Compositions and treatment for multiple sclerosis
GB9218027D0 (en) Novel method of treatment
GB9424913D0 (en) Enhancement of treatment processes
PL314588A1 (en) Application of pentoxyphyline in treatment of sclerosis multiplex
GB2308065B (en) Treatment of multiple sclerosis (MS) and other demyelinating conditions
GB9202196D0 (en) Method of treatment
ZA958391B (en) Treatment of multiple sclerosis (MS) and other demyelinating conditions
GB9321679D0 (en) Treatment of substrates
GB9415902D0 (en) Method of treatment
AU3512193A (en) Flexibility enhancement agent and method of use
GB9201391D0 (en) Method of treatment
GB9408585D0 (en) Treatment of metal granules
GB9407335D0 (en) Method of treatment
GB9218597D0 (en) Novel method of treatment
GB9414652D0 (en) Method of treatment
GB9212535D0 (en) Treatment of boimass
GB9307004D0 (en) Method of treatment
GB9321971D0 (en) Method of treatment
GB9321796D0 (en) Method of treatment

Legal Events

Date Code Title Description
773K Patent revoked under sect. 73(2)/1977

Free format text: PATENT REVOKED ON 20040210